NPM1 and endometrium adenocarcinoma: In this study, NPM1 immunostaining frequency and expression level was found to be linked to the clinical stage of endometrial carcinoma, and in vitro studies using FIGO stages I human endometrial adenocarcinoma cells in primary culture demonstrated that ERα-mediated signaling regulated expression of NPM1.